Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

04:55
02/22/19
02/22
04:55
02/22/19
04:55

Global Blood Therapeutics participates in a conference call with JPMorgan

Biotech Analyst Kasimov holds a conference call with CEO Love and CFO Farrow on February 22 at 10 am hosted by JPMorgan.

  • 22

    Feb

GBT Global Blood Therapeutics
$50.04

-0.45 (-0.89%)

12/04/18
PIPR
12/04/18
NO CHANGE
Target $80
PIPR
Overweight
Piper continues to like 2019 setup for Global Blood Therapeutics
Piper Jaffray analyst Danielle Brill says she continues to like the 2019 setup for Global Blood Therapeutics after the company announced an agreement with the FDA on an accelerated filing strategy for voxelotor in sickle cell disease. The analyst sees two "major de-risking" events that should drive shares higher over the next 12 months: complete Phase 3 Hope data in Q1 and a positive outcome from or lack of FDA panel on voxelotor in second half of 2019. She reiterates an Overweight rating on Global Blood with an $80 price target.
12/04/18
RHCO
12/04/18
NO CHANGE
Target $90
RHCO
Buy
Global Blood Therapeutics price target raised to $90 from $70 at SunTrust
SunTrust analyst Edward Nash raised his price target on Global Blood Therapeutics to $90 and kept his Buy rating based on the positive prevailiing sentiment around the approvability and utilization of voxelotor at ASH. The analyst further notes that he is convinced that the totality of evidence overwhelmingly favors approval, adding that while a statistically significant improvement in vaso-occlusive crisis was not met, its "dose-dependent positive trends and benign safety profile" give him confidence in his bullish view.
01/03/19
WBLR
01/03/19
NO CHANGE
WBLR
Outperform
Global Blood Therapeutics named a top pick for 2019 at William Blair
William Blair analyst Raju Prasad calls Global Blood Therapeutics his top pick for 2019. The analyst's dive into transcranial doppler ultrasound and stroke risk in patients with sickle cell disease provides him with additional confidence on the use of TCD flow velocity as a confirmatory trial endpoint for voxelotor ahead of Global Blood's pre-new drug application meeting anticipated to occur in the first quarter. Overall, he views the stock as "substantially de-risked" with the completion of 24 weeks of therapy in the additional 118 enrolled patients in the study. He also sees Global Blood as a potential takeout candidate given the "significant" unmet medical need in sickle cell disease, the "impressive" data shown in patients with or without concomitant hydroxyurea, and the alignment of a once-daily, oral therapy dosed in perpetuity with the large pharma commercial model. He keeps an Outperform rating on shares of Global Blood Therapeutics.
01/11/19
WELS
01/11/19
NO CHANGE
WELS
Outperform
Global Blood meeting brings increased confidence in approval, says Wells Fargo
Wells Fargo analyst Jim Birchenough says a meeting with Global Blood Therapeutics management has increased his confidence in the company's approval chances. The focus of the meeting was on recent pivotal data for hemoglobin modifier voxelotor in Sickle Cell Disease, plans for accelerated approval filing and confirmatory study and pre commercial preparation, Birchenough tells investors in a research note. He left with continued confidence in the strength of the company's data, the likelihood of an early 2020 approval and its commercial opportunity. The analyst keeps an Outperform rating on Global Blood.

TODAY'S FREE FLY STORIES

SAM

Boston Beer

$345.20

-6.42 (-1.83%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Hot Stocks
Boston Beer, National Hockey League announce multiyear U.S. partnership »

The Boston Beer Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

LYFT

Lyft

$46.45

-0.84 (-1.78%)

, UBER

Uber

$32.52

-1.31 (-3.87%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Recommendations
Lyft, Uber analyst commentary  »

Lyft should be bought on…

LYFT

Lyft

$46.45

-0.84 (-1.78%)

UBER

Uber

$32.52

-1.31 (-3.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SDXAY

Sodexo

$0.00

(0.00%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Hot Stocks
Sodexo confirms 34% carbon emissions reduction target by 2025 »

Sodexo confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Conference/Events
UBS to hold a conference »

Future of Retail…

AJG

Arthur J. Gallagher

$88.78

-0.64 (-0.72%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Hot Stocks
Arthur J. Gallagher acquires The Human Capital Group, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$172.68

-4.23 (-2.39%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

, CHWY

Chewy

$26.44

-1.06 (-3.85%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Plus Therapeutics…

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

CHWY

Chewy

$26.44

-1.06 (-3.85%)

ALV

Autoliv

$78.20

-1.06 (-1.34%)

PSTV

Plus Therapeutics

$7.96

-0.34 (-4.10%)

TELL

Tellurian

$8.69

0.105 (1.22%)

RKDA

Arcadia Biosciences

$5.29

-0.23 (-4.17%)

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

AKS

AK Steel

$2.41

-0.05 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 31

    Oct

ABMD

Abiomed

$193.14

0.48 (0.25%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Federal Court of Justice in Germany rules in favor of Abiomed's Impella patents »

The highest court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MU

Micron

$49.17

-0.65 (-1.30%)

08:58
09/23/19
09/23
08:58
09/23/19
08:58
Recommendations
Micron analyst commentary  »

Deutsche comfortable with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

, NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Recommendations
Cirrus Logic, NXP Semiconductors, Texas Instruments analyst commentary  »

Teardown confirms Cirrus…

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

, ROKU

Roku

$107.98

-25.735 (-19.25%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Options
Notable open interest changes for September 23rd »

Friday's total…

NFLX

Netflix

$270.66

-15.92 (-5.56%)

ROKU

Roku

$107.98

-25.735 (-19.25%)

BAC

Bank of America

$29.57

-0.23 (-0.77%)

AAPL

Apple

$217.69

-3.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 16

    Oct

  • 16

    Oct

SABR

Sabre

$23.11

0.12 (0.52%)

08:54
09/23/19
09/23
08:54
09/23/19
08:54
Hot Stocks
Sabre signs long-term agreement with Magnum Travel Services »

Sabre announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$156.29

-0.66 (-0.42%)

08:53
09/23/19
09/23
08:53
09/23/19
08:53
Recommendations
Dollar General analyst commentary  »

Dollar General price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 30

    Sep

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

08:51
09/23/19
09/23
08:51
09/23/19
08:51
Downgrade
Cleveland-Cliffs rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

INPX

Inpixon

$0.13

0.0013 (0.98%)

08:50
09/23/19
09/23
08:50
09/23/19
08:50
Hot Stocks
Inpixon's Jibestream signs teaming agreement with IDENTOS »

Jibestream announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/23/19
09/23
08:50
09/23/19
08:50
General news
NY Fed's repo results: Fed's repo totaled $65.75 B »

NY Fed's repo…

CGNX

Cognex

$48.20

-2.28 (-4.52%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Recommendations
Cognex analyst commentary  »

Cognex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$21.70

-0.26 (-1.18%)

, X

U.S. Steel

$10.81

-0.25 (-2.26%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Downgrade
Alcoa, U.S. Steel, Commercial Metals, Nucor, Steel Dynamics, Stelco Holdings rating change  »

JPMorgan double…

AA

Alcoa

$21.70

-0.26 (-1.18%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

NUE

Nucor

$52.62

-0.08 (-0.15%)

STLD

Steel Dynamics

$30.38

-0.32 (-1.04%)

STZHF

Stelco Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Hot Stocks
Abeona recieves clinical hold letter from FDA over Phase 3 trial for EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FNB

F.N.B.

$11.38

-0.045 (-0.39%)

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
F.N.B. announces $150M stock repurchase program »

F.N.B. announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
Resverlogix to present BETonMACE trial results at AHA Scientific Sessions »

Resverlogix announced the…

PRSP

Perspecta

$26.29

-0.005 (-0.02%)

08:46
09/23/19
09/23
08:46
09/23/19
08:46
Hot Stocks
Perspecta awarded $657M extension of NGEN contract with U.S. Dept. of Navy »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Hot Stocks
Apple partners with Oprah Winfrey to bring Oprah's Book Club to Apple »

Apple and Oprah Winfrey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$155.23

0.19 (0.12%)

, HEXO

HEXO Corp

$4.37

0.425 (10.79%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BYND

Beyond Meat

$155.23

0.19 (0.12%)

HEXO

HEXO Corp

$4.37

0.425 (10.79%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

ABBV

AbbVie

$72.46

0.78 (1.09%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

COTY

Coty

$10.17

-0.1 (-0.97%)

ADI

Analog Devices

$115.30

-0.72 (-0.62%)

NOK

Nokia

$5.30

0.145 (2.81%)

IMMU

Immunomedics

$16.60

-0.44 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Nov

08:45
09/23/19
09/23
08:45
09/23/19
08:45
General news
U.S. Chicago National Activity index rose 0.51 points to 0.10 in August »

U.S. Chicago National…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.